bioAffinity Technologies and Pictor Partner to Advance Next-Generation Precision Diagnostics for Asthma and COPD bioAffinity Technologies, Inc., a biotechnology company focused on developing innovative cancer diagnostics and targeted therapeutics, has announced a strategic collaboration with Pictor®, Inc., a company specializing…
The BRAIN Foundation and Stanford Medicine Launch Aurora Research Network to Advance Evidence-Based Care for Severe Neuropsychiatric Deterioration The BRAIN Foundation, in partnership with Stanford Medicine, has announced the launch of the Aurora Research Network (ARN), a nationwide collaborative initiative…
Cellares and Papillon Therapeutics Partner to Automate Manufacturing of PPL-001 Gene-Edited Cell Therapy for Friedreich’s Ataxia Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO) dedicated to advancing cell therapy manufacturing, has announced a strategic collaboration with Papillon Therapeutics…
Ashlins Pharmaceuticals Signs Exclusive Global Licensing Agreement with Lee’s Pharmaceutical Holdings to Advance Interferon Alpha-2b Drug Development Ashlins Pharmaceuticals has announced that its wholly owned subsidiary, Ashlins Ocular Pharmaceuticals, Inc., has entered into an exclusive license and supply agreement with…
Flashpoint Therapeutics Celebrates Founder Professor Chad A. Mirkin’s Selection for the 2027 ACS Priestley Medal Flashpoint Therapeutics, a biotechnology company focused on advancing next-generation nanomedicines, has announced that its founder, Professor Chad A. Mirkin, has been named the recipient of…
Immunomic Therapeutics Doses First Patient in Phase 1 Trial of ITI-5000 Therapeutic Cancer Vaccine for Triple-Negative Breast Cancer Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company and U.S.-based subsidiary of HLB, has announced an important milestone in the development of…
Bayer and Henry Ford Health Form Strategic Partnership to Expand Patient Access to Clinical Trials and Accelerate Medical Innovation Bayer, a global life sciences company with a broad portfolio spanning pharmaceuticals, consumer health, and crop science, has announced a strategic…
Takeda Reports New Phase 3 Data Showing Zasocitinib Delivers Strong Skin Clearance Across Difficult-to-Treat Areas in Plaque Psoriasis Takeda has announced new findings from its two pivotal Phase 3 clinical studies evaluating zasocitinib (TAK-279), a next-generation oral tyrosine kinase 2…
Cutera and Restimulate Health Partner to Advance Technology-Driven Rehabilitation with truFlex Integration CUTERA, INC., a global provider of aesthetic and dermatologic technologies, has announced a strategic partnership with Restimulate Health, a healthcare company focused on enhancing rehabilitation outcomes through clinically…
Anova Enterprises and Nouveau Biosciences Partner to Advance Clinical Development of Kromastat for Hard-to-Treat Cancers Anova Enterprises, Inc., a technology-enabled contract research organization (CRO) dedicated to accelerating the development of innovative therapies, has announced a strategic partnership with Nouveau Biosciences,…
Infusion for Health Expands Home Infusion Services to Enhance Patient Access and Flexible Specialty Care Infusion for Health, a leading provider of specialty infusion therapy services, has announced the continued expansion of its Home Infusion division, reinforcing its commitment to…
Revel Pharmaceuticals Publishes Nature Communications Study Demonstrating Enzyme That Reverses Age-Related Protein Damage Revel Pharmaceuticals has announced the publication of new research in Nature Communications describing a breakthrough enzyme capable of reversing a long-recognized form of age-related protein damage. The…